Strategies to reduce serious bacterial infections and overdose among people who inject drugs
减少注射吸毒者严重细菌感染和过量用药的策略
基本信息
- 批准号:10545659
- 负责人:
- 金额:$ 16.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
Serious bacterial infections including infective endocarditis and skin and soft tissue infections are
among the most common medical complications in persons who inject drugs (PWID). Hospitalizations for
injection-related infective endocarditis increased twelve-fold between 2010 and 2015 and for heroin-related
skin and soft tissue infections doubled over the last two decades. Costs of these diseases have also increased
dramatically.
While there are ongoing hospital-based programs to reduce injection-related bacterial infections, their
long-term effectiveness, costs, and cost-effectiveness are unknown. Longitudinal investigation of these
interventions is urgently needed to improve outcomes given the rapid expansion of the US opioid epidemic, but
is challenging due to the relapsing nature of OUD, the heterogeneous nature of persons who inject opioids,
and the shifting nature of the drug supply. Simulation modeling can augment evidence from trials by projecting
the clinical and economic outcomes over longer time horizons for different populations. This proposed research
will use simulation modeling to examine the impact of changes in injection opioid use practices as well as
hospital-based interventions aimed at addressing the underlying OUD on the incidence of injection-related
bacterial infections with the following scientific aims:
Aim 1: To develop a simulation model of injection opioid use to project long-term incidence, outcomes, and
costs of injection-related infective endocarditis, skin and soft tissue infections, and overdose. Aim 2: To
estimate the clinical impact, costs, and cost-effectiveness of hospital-initiated addiction care and rapid-access
linkage to post-hospital medication treatment for persons who inject opioids. Aim 3: To perform a
comprehensive economic evaluation alongside an ongoing clinical trial and to use the simulation model to
estimate the long-term clinical effectiveness of a hospital-based skin and needle hygiene program aimed to
prevent bacterial infections among persons who inject opioids.
During the K01 project period, the candidate will develop a specific skill set in three primary domains:
(1) advanced quantitative methods for simulation modeling; (2) understanding the design, operationalization,
and evaluation of hospital-based interventions for PWID; and (3) measuring healthcare utilization and cost-
effectiveness analyses alongside clinical trials. Training will be accomplished through an intensive combination
of formal structured courses, training workshops and field experiences, applied research experience, and
focused mentorship in mathematical modeling, biostatistics, addiction, hospital-based interventions, and health
economics. Acquisition of these skills will allow the candidate to accomplish his long-term goal, which is to
become an independently-funded investigator and global expert on clinical decision making and health policy
at the intersection of substance use and infectious diseases.
项目摘要
严重的细菌感染,包括感染性心内膜炎和皮肤及软组织感染,
注射毒品者最常见的医疗并发症之一(PWID)。住院治疗
2010年至2015年间,注射相关感染性心内膜炎增加了12倍,
皮肤和软组织感染在过去二十年中翻了一番。这些疾病的费用也增加了
戏剧性地。
虽然有正在进行的以医院为基础的计划,以减少注射相关的细菌感染,
长期有效性、成本和成本效益尚不清楚。纵向调查这些
鉴于美国阿片类药物流行的迅速扩大,迫切需要采取干预措施来改善结果,
由于OUD的复发性质,注射阿片类药物的人的异质性,
以及毒品供应的变化模拟建模可以通过预测来增加试验的证据
不同人群在较长时间范围内的临床和经济结果。这项拟议的研究
将使用模拟建模来研究注射阿片类药物使用实践变化的影响,
以医院为基础的干预措施,旨在解决潜在的OUD对注射相关的发病率
细菌感染,具有以下科学目的:
目的1:建立阿片类药物注射使用的模拟模型,以预测长期发病率、结局和
注射相关感染性心内膜炎、皮肤和软组织感染以及用药过量的费用。目标2:
估计医院发起的成瘾护理和快速访问的临床影响,成本和成本效益
与注射类阿片者住院后药物治疗的联系。目标3:执行
综合经济评估以及正在进行的临床试验,并使用模拟模型,
评估以医院为基础的皮肤和针头卫生计划的长期临床效果,
预防注射阿片类药物者的细菌感染。
在K 01项目期间,候选人将在三个主要领域发展特定技能:
(1)仿真建模的先进定量方法;(2)理解设计,可操作性,
和评估基于医院的PWID干预措施;(3)测量医疗保健利用和成本-
有效性分析以及临床试验。培训将通过强化组合完成
正规的结构化课程、培训讲习班和实地经验、应用研究经验,以及
在数学建模,生物统计学,成瘾,医院为基础的干预和健康集中辅导
经济学掌握这些技能将使候选人能够实现他的长期目标,即
成为独立资助的研究者和临床决策和卫生政策的全球专家
物质使用和传染病的交叉点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joshua Adam Barocas其他文献
Joshua Adam Barocas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joshua Adam Barocas', 18)}}的其他基金
Development of a novel community-based high-performance surveillance network for drug use
开发基于社区的新型高性能毒品使用监测网络
- 批准号:
10512220 - 财政年份:2020
- 资助金额:
$ 16.11万 - 项目类别:
Strategies to reduce serious bacterial infections and overdose among people who inject drugs
减少注射吸毒者严重细菌感染和过量用药的策略
- 批准号:
10408117 - 财政年份:2020
- 资助金额:
$ 16.11万 - 项目类别:
Strategies to reduce serious bacterial infections and overdose among people who inject drugs
减少注射吸毒者严重细菌感染和过量用药的策略
- 批准号:
10625422 - 财政年份:2020
- 资助金额:
$ 16.11万 - 项目类别:
Strategies to reduce serious bacterial infections and overdose among people who inject drugs
减少注射吸毒者严重细菌感染和过量用药的策略
- 批准号:
10038052 - 财政年份:2020
- 资助金额:
$ 16.11万 - 项目类别:
Development of a novel community-based high-performance surveillance network for drug use
开发基于社区的新型高性能毒品使用监测网络
- 批准号:
10054384 - 财政年份:2020
- 资助金额:
$ 16.11万 - 项目类别:
相似国自然基金
Map/Reduce数据处理平台中内存级数据缓存技术研究
- 批准号:61202075
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
云计算环境下海量RDF数据管理系统核心技术研究
- 批准号:61170010
- 批准年份:2011
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Building multisectoral capacity to plan for the development and evaluation of an interactive, inclusive and patient-centered knowledge transfer tool to reduce stigma around autism
建立多部门能力,规划开发和评估交互式、包容性和以患者为中心的知识转移工具,以减少自闭症的耻辱
- 批准号:
487939 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Miscellaneous Programs
Development of a transdiagnostic intervention for adolescents at risk for serious mental illness
为有严重精神疾病风险的青少年制定跨诊断干预措施
- 批准号:
10739558 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Ketamine to reduce postpartum depression and pain after cesarean delivery
氯胺酮可减轻产后抑郁和剖腹产后的疼痛
- 批准号:
10752797 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics
评估在社区肿瘤诊所接受治疗的一组癌症患者中大麻和大麻素使用的益处和危害
- 批准号:
10792076 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Improving Buprenorphine Retention with Transcutaneous Auricular Neurostimulation for Patients with Co-occurring Posttraumatic Stress Disorder and Opioid Use Disorder
通过经皮耳廓神经刺激改善同时发生的创伤后应激障碍和阿片类药物使用障碍患者的丁丙诺啡保留
- 批准号:
10775120 - 财政年份:2023
- 资助金额:
$ 16.11万 - 项目类别:
Focal mass drug administration (fMDA) to reduce Plasmodium vivax transmission, a pragmatic cluster randomized controlled trial in Peru
旨在减少间日疟原虫传播的集中集中药物管理(fMDA),这是秘鲁的一项实用整群随机对照试验
- 批准号:
10488139 - 财政年份:2022
- 资助金额:
$ 16.11万 - 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
- 批准号:
10650820 - 财政年份:2022
- 资助金额:
$ 16.11万 - 项目类别:
A novel intervention to improve care for older sexual and gender minority (SGM) adults with serious illness and especially those with Alzheimer’s Disease and Related Dementias (ADRD)
一种新的干预措施,旨在改善对患有严重疾病的老年性和性别少数 (SGM) 成年人,特别是患有阿尔茨海默氏病和相关痴呆症 (ADRD) 的老年人的护理
- 批准号:
10700800 - 财政年份:2022
- 资助金额:
$ 16.11万 - 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
- 批准号:
10925898 - 财政年份:2022
- 资助金额:
$ 16.11万 - 项目类别:
Efficacy and Safety of Stellate Ganglion Block for Post-traumatic Stress Disorder in Veterans
星状神经节阻滞治疗退伍军人创伤后应激障碍的疗效和安全性
- 批准号:
10252644 - 财政年份:2022
- 资助金额:
$ 16.11万 - 项目类别: